FULCRUM THERAPEUTICS INC's ticker is FULC and the CUSIP is 359616109. A total of 107 filers reported holding FULCRUM THERAPEUTICS INC in Q3 2022. The put-call ratio across all filers is 0.06 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $10,403,604 | +34.5% | 2,343,154 | 0.0% | 3.92% | -43.9% |
Q2 2023 | $7,732,408 | +15.8% | 2,343,154 | 0.0% | 6.99% | +46.4% |
Q1 2023 | $6,677,989 | -60.9% | 2,343,154 | 0.0% | 4.77% | -34.2% |
Q4 2022 | $17,058,161 | -10.0% | 2,343,154 | 0.0% | 7.25% | -34.5% |
Q3 2022 | $18,956,000 | +65.1% | 2,343,154 | 0.0% | 11.08% | +46.7% |
Q2 2022 | $11,481,000 | -79.3% | 2,343,154 | 0.0% | 7.55% | -62.8% |
Q1 2022 | $55,416,000 | +33.7% | 2,343,154 | 0.0% | 20.30% | +70.3% |
Q4 2021 | $41,450,000 | -37.3% | 2,343,154 | 0.0% | 11.92% | -20.5% |
Q3 2021 | $66,100,000 | +169.2% | 2,343,154 | 0.0% | 15.00% | +28.3% |
Q2 2021 | $24,556,000 | -11.0% | 2,343,154 | 0.0% | 11.69% | +15.0% |
Q1 2021 | $27,602,000 | +0.6% | 2,343,154 | 0.0% | 10.17% | +15.5% |
Q4 2020 | $27,438,000 | +47.7% | 2,343,154 | 0.0% | 8.80% | +37.6% |
Q3 2020 | $18,581,000 | -56.6% | 2,343,154 | 0.0% | 6.40% | -67.6% |
Q2 2020 | $42,856,000 | +53.2% | 2,343,154 | 0.0% | 19.74% | -22.8% |
Q1 2020 | $27,977,000 | -28.2% | 2,343,154 | 0.0% | 25.58% | +5.2% |
Q4 2019 | $38,990,000 | +150.6% | 2,343,154 | 0.0% | 24.31% | +52.7% |
Q3 2019 | $15,559,000 | – | 2,343,154 | – | 15.92% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
TRV GP IV, LLC | 2,343,154 | $10,403,604 | 3.92% |
SUVRETTA CAPITAL MANAGEMENT, LLC | 5,718,881 | $25,391,832 | 1.37% |
COWEN AND COMPANY, LLC | 4,308,359 | $19,129,113 | 1.34% |
RA Capital Management | 11,609,704 | $51,547,086 | 1.02% |
RTW INVESTMENTS, LP | 5,818,804 | $25,835,490 | 0.54% |
Acuitas Investments, LLC | 134,811 | $598,561 | 0.35% |
Simplify Asset Management Inc. | 570,519 | $2,533,104 | 0.29% |
Vivo Capital, LLC | 520,000 | $2,308,800 | 0.25% |
BRANDYWINE MANAGERS, LLC | 26,127 | $116,004 | 0.20% |
DENALI ADVISORS LLC | 70,600 | $313,464 | 0.11% |